Institutional shares held 175 Million
2.9K calls
6K puts
Total value of holdings $1.69B
$28K calls
$58K puts
Market Cap $2.4B
247,824,992 Shares Out.
Institutional ownership 70.54%
# of Institutions 117


Latest Institutional Activity in LYEL

Top Purchases

Q1 2025
Foresite Capital Management Iv, LLC Shares Held: 16M ($155M)
Q1 2025
Almitas Capital LLC Shares Held: 2.48M ($24.1M)
Q1 2025
Citadel Advisors LLC Shares Held: 4.51M ($43.7M)
Q1 2025
Nuveen, LLC Shares Held: 641K ($6.21M)
Q1 2025
Acadian Asset Management LLC Shares Held: 661K ($6.4M)

Top Sells

Q1 2025
Millennium Management LLC Shares Held: 43K ($416K)
Q1 2025
D. E. Shaw & Co., Inc. Shares Held: 77.2K ($748K)
Q1 2025
Jacobs Levy Equity Management, Inc Shares Held: 559K ($5.42M)
Q1 2025
Ubs Group Ag Shares Held: 110K ($1.07M)
Q1 2025
Price T Rowe Associates Inc Shares Held: 6.48M ($62.8M)

About LYEL

Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate for the treatment of non-small cell lung cancer and triple negative breast cancers; LYL845, that targets multiple solid tumors; and NY-ESO-1 for synovial sarcoma and other solid tumor indications. The company entered into research and development collaboration and license agreement with GlaxoSmithKline for NY-ESO-1 program. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.


Insider Transactions at LYEL

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1.58M Shares
From 11 Insiders
Grant, award, or other acquisition 809K shares
Open market or private purchase 769K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on LYEL

Follow Lyell Immunopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYEL shares.

Notify only if

Insider Trading

Get notified when an Lyell Immunopharma, Inc. insider buys or sells LYEL shares.

Notify only if

News

Receive news related to Lyell Immunopharma, Inc.

Track Activities on LYEL